Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT03708224 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Carcinoma
Squamous Cell Carcinoma
Head and Neck Cancer

Interventions

BIOLOGICAL: Atezolizumab
BIOLOGICAL: Tocilizumab
BIOLOGICAL: Tiragolumab

Sponsor

Alain Algazi

Collaborators

[object Object]
[object Object]